Bevacizumab, 5 mg

This product is a highly concentrated solution of monoclonal antibody Bevacizumab, specifically formulated to meet the needs of researchers and scientists working with small-scale projects. Bevacizumab plays a crucial role in various fields, including oncology research and clinical trials, where its ability to inhibit angiogenesis is essential. Its high purity and precise formulation make it an ideal choice for those who require a reliable source of this vital compound.

Everyday Benefits

• Facilitates the development of new treatments for various types of cancer through its anti-angiogenic properties.
• Allows researchers to conduct experiments with confidence using a reliable and consistent supply of Bevacizumab.
• Ideal for use in laboratories where precise control over the concentration of Bevacizumab is necessary.
• Can be easily incorporated into existing protocols due to its well-characterized properties.
• May be used in combination with other compounds to enhance its effects.

Convenient Quantity for Regular Use

Teams selecting Bevacizumab typically match the A to Z category and the container format to the task.